Monday, May 16, 2022 12:02:58 PM
I guess that I need to amp up my game here a bit and start engaging ZIVO again.
Dahl never struck me as screwing the pooch ..... but did strike me as parasite vs producer (never getting things done which is basically screwing the pooch). Those that have been around a long time will understand that reference.
I'm still not understanding the massive awards that happened over the last couple years either ..... for what ? I believe some of those had vesting requirements so millions of potential options/warrants would likely be cancelled .... a good thing but under the hood.
On legal front with Dahl ... doesn't look like its moved to that stage based on the filings. Its been 4+ months. Would think he'd have moved to file by now if he feels wronged. Surely ZIVO and its investors have been wronged. Yaldoo and HEP Investments ... condition of their investment was bring in Dahl as CEO. Don't remember the exact number but they funded in the neighborhood of $15-20 million. At this point that bought us all alot of IP ..... but no revenues ... and now HEP Investments doesn't have right to the IP any more with the stock conversion .... they have lost several million. Twas interesting one of the filings noting Yaldoo's presence at Dahl dismissal. Strange. But someone who also made it a point that Dahl was to be CEO to receive funding. Yaldoo losing millions with no claim to anything now.
Dahl ? What did he lose ? Maybe about $4K on his 100K purchase of ZIVO stock many years ago ?
Anyway .... CEO is responsible ..... BoD is responsible for oversight. Payne and Maggiore are responsible. Of course ... some thing ... or accumulation of some things .... finally made them exercise their oversight and make a move on Dahl.
Dahl infamous quote ...... "the doors are still open right ? Would you prefer the opposite ?" I think Payne can do some things here. But big pharma arena is not a place things happen quickly and ZIVO isn't in the best bargaining position.
Not telling you anything you don't already know I guess .... but I have more faith in Payne ..... than I ever had in Dahl. The questions started on Dahl's viability the day he was hired. Unfortunately a bad move for ZIVO to keep him around for a decade. Lots of excuses and time lost. Those same questions don't apply to Payne.
Amigo Mike
Recent ZIVO News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/26/2024 05:36:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/26/2024 12:05:12 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 04/09/2024 03:49:14 PM
- Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/14/2024 01:16:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:45:37 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 02/15/2024 01:54:37 PM
- ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study • Business Wire • 02/07/2024 09:54:00 PM
- ZIVO Bioscience Announces Uplisting to OTCQB Market • Business Wire • 01/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:11:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:17:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:23:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:12:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 02:29:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:21:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:18:41 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 10/30/2023 05:20:31 PM
- ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens • Business Wire • 10/30/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 12:56:59 PM
- ZIVO Bioscience Announces Reverse Stock Split • Business Wire • 10/26/2023 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/04/2023 09:08:51 PM
- ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference • GlobeNewswire Inc. • 10/03/2023 12:30:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM